EBS - Emergent BioSolutions misses by $0.03 misses on revenue November, 01 2018 04:39 PM Emergent Biosolutions Inc. Emergent BioSolutions (NYSE:EBS): Q3 Non-GAAP EPS of $0.55 misses by $0.03; GAAP EPS of $0.41 misses by $0.14. More news on: Emergent BioSolutions Inc., Earnings news and commentary, Healthcare stocks news, Read more ...